IP Library › Granted Patent US 12,251,436
Granted Patent B2
US 12,251,436 · App. 17/546,967 · Granted Mar 18, 2025

Recombinant influenza viruses with stabilized HA for replication in eggs

Inventors: Yoshihiro Kawaoka (Middleton, WI); Shinya Yamada (Bunkyo-ku, JP); Shiho Chiba (Madison, WI)
Assignees: Wisconsin Alumni Research Foundation (WARF); The University of Tokyo
A61K39/145A61K9/0019A61K9/0043A61P31/16C07K14/005C12N7/00C12N9/2402C12N15/63C12N2760/16021C12N2760/16022C12N2760/16034C12N2760/16051C12Y302/01018
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,251,436
App. No.
17/546,967
Granted
Mar 18, 2025
Kind
B2
Abstract

Modified influenza virus neuraminidases are described herein that improve viral replication, thus improving the yield of vaccine viruses. Expression of such modified. neuraminidases by influenza virus may also stabilize co-expressed hemagglutinins so that the hemagglutinins do not undergo mutation.

Claims (22)

1. An isolated recombinant influenza virus comprising a selected NA viral segment encoding at least two selected residues in NA, wherein the residues are selected from residue S, T, I, L, A, N, W, Y, P, V, or G at position 245 and residue S, T, P, Y, W, A, N, I, L, or V at position 346, wherein the numbering is relative to SEQ ID NO:3, wherein the recombinant influenza virus has enhanced replication in avian eggs or has a reduction in HA mutations when grown in avian eggs relative to a corresponding influenza virus that has a NA that encodes an asparagine at residue 245, or encodes a glycine at residue 346, or any combination thereof.

2. The isolated virus of claim 1 wherein the NA further encodes residue G, Q, S, T, Y, C or W at position 347 or residue K, R or H at position 369.

3. The isolated recombinant influenza virus of claim 1 wherein the NA viral segment encodes a NA that has at least 90% amino acid sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50 or SEQ ID NO:54.

4. The isolated recombinant influenza virus of claim 1 wherein the NA viral segment encodes a N2, N3, N7, or N9.

5. The isolated recombinant influenza virus of claim 1 wherein the residue at position 245 is S or the residue at position 346 is V.

6. The isolated recombinant influenza virus of claim 2 wherein the residue at position 347 is G or Q.

7. The isolated recombinant influenza virus of claim 1 wherein the residue at position 245 is S, T, I, L, A, or V, or any combination thereof.

8. The isolated recombinant influenza virus of claim 1 which comprises PA, PB1, PB2, NP, M, and NS viral segments having at least 85% nucleic acid sequence identity to SEQ ID Nos. 24 to 29 or 39 to 44 or encoding a polypeptide having at least 80% amino acid sequence identity to a polypeptide encoded by SEQ ID Nos. 24 to 29 or 39 to 44.

9. A method to prepare influenza virus, comprising: contacting a cell with:

a vector for vRNA production comprising a promoter operably linked to an influenza virus PA DNA linked to a transcription termination sequence, a vector for vRNA production comprising a promoter operably linked to an influenza virus PB1 DNA linked to a transcription termination sequence, a vector for vRNA production comprising a promoter operably linked to an influenza virus PB2 DNA linked to a transcription termination sequence, a vector for vRNA production comprising a promoter operably linked to an influenza virus HA DNA linked to a transcription termination sequence, a vector for vRNA production comprising a promoter operably linked to an influenza virus NP DNA linked to a transcription termination sequence, a vector for vRNA production comprising a promoter operably linked to an influenza virus NA DNA linked to a transcription termination sequence, a vector for vRNA production comprising a promoter operably linked to an influenza virus M DNA linked to a transcription termination sequence, and a vector for vRNA production comprising a promoter operably linked to an influenza virus NS DNA linked to a transcription termination sequence, wherein the PB1, PB2, PA, NP, NS, and M DNAs in the vectors for vRNA production are from one or more influenza vaccine virus isolates, wherein the NA DNA in the vector for vRNA production encodes a NA having a residue selected from S, T, I, L, A, N, W, Y, P, V, or G at position 245 and residue S, T, P, Y, W, A, N, I, L, or V at position 346, wherein the numbering for NA residues is relative to SEQ ID NO:3; and

a vector for mRNA production comprising a promoter operably linked to a DNA segment encoding influenza virus PA, a vector for mRNA production comprising a promoter operably linked to a DNA segment encoding influenza virus PB1, a vector for mRNA production comprising a promoter operably linked to a DNA segment encoding influenza virus PB2, and a vector for mRNA production comprising a promoter operably linked to a DNA segment encoding influenza virus NP, and optionally a vector for mRNA production comprising a promoter operably linked to a DNA segment encoding influenza virus HA, a vector for mRNA production comprising a promoter operably linked to a DNA segment encoding influenza virus NA, a vector for mRNA production comprising a promoter operably linked to a DNA segment encoding influenza virus M1, a vector for mRNA production comprising a promoter operably linked to a DNA segment encoding influenza virus M2, or a vector for mRNA production comprising a promoter operably linked to a DNA segment encoding influenza virus NS2; in an amount effective to yield infectious influenza virus.

10. The method of claim 9 wherein the NA has at least 90% amino acid sequence identity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:48, SEQ ID NO:49, or SEQ ID NO: 54.

11. The method of claim 9 wherein the residue at position 347 is G or Q or the residue at position 245 is S.

12. The method of claim 9 wherein the virus comprises PA, PB1, PB2, NP, M, and NS viral segments having at least 85% nucleic acid sequence identity to SEQ ID Nos. 24 to 29 or 39 to 44 or encoding a polypeptide having at least 80% amino acid sequence identity to a polypeptide encoded by SEQ ID Nos. 24 to 29 or 39 to 44.

13. The method of claim 9 wherein the NA further encodes residue G, Q, S, T, Y, C or W at position 347 or residue K, R or H at position 369.

14. An isolated virus prepared by the method of claim 9 .

15. A method of immunizing an avian or a mammal, comprising: administering to the avian or the mammal a composition having an effective amount of the virus of claim 1 .

16. The method of claim 15 wherein the composition comprises at least one other different influenza virus.

17. The method of claim 15 wherein the mammal is a human.

18. The method of claim 15 wherein the composition is administered intranasally.

19. The method of claim 15 wherein the composition is administered via injection.

20. A method comprising passaging the virus of claim 1 in eggs.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2021
From: KAWAOKA, YOSHIHIRO
To: WISCONSIN ALUMNI RESEARCH FOUNDATION; THE UNIVERSITY OF TOKYO
Reel/Frame 058498/0537 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2021
From: YAMADA, SHINYA
To: THE UNIVERSITY OF TOKYO
Reel/Frame 058498/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2021
From: CHIBA, SHIHO
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 058498/0622 →
Continuity (4)
Continuation 16170321 · Oct 25, 2018
Provisional Application 62633400 · Feb 21, 2018
Provisional Application 62577049 · Oct 25, 2017
Related Publication 20220202927A1 · Jun 30, 2022
References Cited (400)
US 4071618A · Konobe et al. · 1978 [cited by applicant]
US 4659569A · Mitsuhashi et al. · 1987 [cited by applicant]
US 5166057A · Palese et al. · 1992 [cited by applicant]
US 5578473A · Palese et al. · 1996 [cited by applicant]
US 5716821A · Wertz et al. · 1998 [cited by applicant]
US 5750394A · Palese et al. · 1998 [cited by applicant]
US 5786199A · Palese · 1998 [cited by applicant]
US 5789229A · Wertz et al. · 1998 [cited by applicant]
US 5820871A · Palese et al. · 1998 [cited by applicant]
US 5840520A · Clarke et al. · 1998 [cited by applicant]
US 5854037A · Palese et al. · 1998 [cited by applicant]
US 5948410A · Van Scharrenburg et al. · 1999 [cited by applicant]
US 5994526A · Meulewaeter et al. · 1999 [cited by applicant]
US 6001634A · Palese et al. · 1999 [cited by applicant]
US 6033886A · Conzelmann · 2000 [cited by applicant]
US 6037348A · Colacino et al. · 2000 [cited by applicant]
US 6146642A · Garcia-Sastre et al. · 2000 [cited by applicant]
US 6169175B1 · Frace et al. · 2001 [cited by applicant]
US 6194546B1 · Newton et al. · 2001 [cited by applicant]
US 6270958B1 · Olivo et al. · 2001 [cited by applicant]
US 6271011B1 · Lee et al. · 2001 [cited by applicant]
US 6358733B1 · Motwani et al. · 2002 [cited by applicant]
US 6455298B1 · Groner et al. · 2002 [cited by applicant]
US 6544785B1 · Palese et al. · 2003 [cited by applicant]
US 6656720B2 · Groner et al. · 2003 [cited by applicant]
US 6825036B2 · Makizumi et al. · 2004 [cited by applicant]
US 6843996B1 · Parkin et al. · 2005 [cited by applicant]
US 6872395B2 · Kawaoka · 2005 [cited by applicant]
US 6890710B1 · Palese et al. · 2005 [cited by applicant]
US 6951752B2 · Reiter et al. · 2005 [cited by applicant]
US 6951754B2 · Hoffmann · 2005 [cited by applicant]
US 6974695B2 · Vogels et al. · 2005 [cited by applicant]
US 7037707B2 · Webster et al. · 2006 [cited by applicant]
US 7176021B2 · Kawaoka · 2007 [cited by applicant]
US 7211378B2 · Kawaoka et al. · 2007 [cited by applicant]
US 7226774B2 · Kawaoka · 2007 [cited by applicant]
US 7312064B2 · Hoffmann · 2007 [cited by applicant]
US 7335356B2 · Hart et al. · 2008 [cited by applicant]
US 7507411B2 · Zhou et al. · 2009 [cited by applicant]
US 7566458B2 · Yang et al. · 2009 [cited by applicant]
US 7585657B2 · Kawaoka · 2009 [cited by applicant]
US 7588769B2 · Kawaoka · 2009 [cited by applicant]
US 7601356B2 · Jin et al. · 2009 [cited by applicant]
US 7670837B2 · Schwartz · 2010 [cited by applicant]
US 7682618B2 · Bavari et al. · 2010 [cited by applicant]
US 7723094B2 · Kawaoka et al. · 2010 [cited by applicant]
US 7833788B2 · Pau et al. · 2010 [cited by applicant]
US 7883844B2 · Nouchi et al. · 2011 [cited by applicant]
US 7955833B2 · Reiter et al. · 2011 [cited by applicant]
US 7959930B2 · De Wit et al. · 2011 [cited by applicant]
US 7968101B2 · Kawaoka et al. · 2011 [cited by applicant]
US 7972843B2 · Hoffmann · 2011 [cited by applicant]
US 7993924B2 · Billeter et al. · 2011 [cited by applicant]
US 8012736B2 · Hoffman et al. · 2011 [cited by applicant]
US 8043856B2 · Kawaoka et al. · 2011 [cited by applicant]
US 8048430B2 · Yang et al. · 2011 [cited by applicant]
US 8057806B2 · Kawaoka et al. · 2011 [cited by applicant]
US 8093033B2 · Kemble et al. · 2012 [cited by applicant]
US 8114415B2 · Hoffmann et al. · 2012 [cited by applicant]
US 8119337B2 · Gregersen · 2012 [cited by applicant]
US 8119388B2 · Schwartz et al. · 2012 [cited by applicant]
US 8298805B2 · Kawaoka · 2012 [cited by applicant]
US 8309099B2 · Hoffmann · 2012 [cited by applicant]
US 8354114B2 · Lu et al. · 2013 [cited by applicant]
US 8357376B2 · Liu et al. · 2013 [cited by applicant]
US 8409843B2 · Kemble et al. · 2013 [cited by applicant]
US 8460914B2 · Gregersen · 2013 [cited by applicant]
US 8465960B2 · Kawaoka et al. · 2013 [cited by applicant]
US 8475806B2 · Kawaoka · 2013 [cited by applicant]
US 8507247B2 · Kawaoka et al. · 2013 [cited by applicant]
US 8524497B2 · Reiter et al. · 2013 [cited by applicant]
US 8546123B2 · Lewis · 2013 [cited by applicant]
US 8574591B2 · Hoffmann et al. · 2013 [cited by applicant]
US 8574593B2 · Yang et al. · 2013 [cited by applicant]
US 8580277B2 · Yang et al. · 2013 [cited by applicant]
US 8591914B2 · Yang et al. · 2013 [cited by applicant]
US 8597661B2 · Kawaoka et al. · 2013 [cited by applicant]
US 8679819B2 · Kawaoka · 2014 [cited by applicant]
US 8877209B2 · Kawaoka et al. · 2014 [cited by applicant]
US 8900595B2 · Kawaoka et al. · 2014 [cited by applicant]
US 9101653B2 · Kawaoka et al. · 2015 [cited by applicant]
US 9109013B2 · Kawaoka et al. · 2015 [cited by applicant]
US 9222118B2 · Kawaoka et al. · 2015 [cited by applicant]
US 9254318B2 · Kawaoka et al. · 2016 [cited by applicant]
US 9284533B2 · Bilsel et al. · 2016 [cited by applicant]
US 9474798B2 · Watanabe et al. · 2016 [cited by applicant]
US 9757446B2 · LeFebvre et al. · 2017 [cited by applicant]
US 9890363B2 · Kawaoka · 2018 [cited by applicant]
US 9926535B2 · Kawaoka et al. · 2018 [cited by applicant]
US 9950057B2 · Kawaoka et al. · 2018 [cited by applicant]
US 10053671B2 · Kawaoka et al. · 2018 [cited by applicant]
US 10059925B2 · Kawaoka et al. · 2018 [cited by applicant]
US 10119124B2 · Watanabe et al. · 2018 [cited by applicant]
US 10130697B2 · Watanabe · 2018 [cited by applicant]
US 10172934B2 · Kawaoka et al. · 2019 [cited by applicant]
US 10246686B2 · Kawaoka et al. · 2019 [cited by applicant]
US 10358630B2 · Kawaoka et al. · 2019 [cited by applicant]
US 10494613B2 · Kawaoka et al. · 2019 [cited by applicant]
US 10513692B2 · Kawaoka et al. · 2019 [cited by applicant]
US 10633422B2 · Kawaoka et al. · 2020 [cited by applicant]
US 10808229B2 · Kawaoka et al. · 2020 [cited by applicant]
US 11007262B2 · Watanabe et al. · 2021 [cited by applicant]
US 11046934B2 · Kawaoka et al. · 2021 [cited by applicant]
US 11180737B2 · Kawaoka et al. · 2021 [cited by applicant]
US 11197925B2 · Kawaoka et al. · 2021 [cited by applicant]
US 11197926B2 · Kawaoka et al. · 2021 [cited by applicant]
US 11241492B2 · Kawaoka et al. · 2022 [cited by applicant]
US 11384339B2 · Kawaoka et al. · 2022 [cited by applicant]
US 11389523B2 · Kawaoka et al. · 2022 [cited by applicant]
US 11390649B2 · Kawaoka et al. · 2022 [cited by applicant]
US 11739303B2 · Kawaoka et al. · 2023 [cited by applicant]
US 11807872B2 · Kawaoka et al. · 2023 [cited by applicant]
US 11851648B2 · Kawaoka et al. · 2023 [cited by applicant]
US 20020010143A1 · Barbosa et al. · 2002 [cited by applicant]
US 20020164770A1 · Hoffmann · 2002 [cited by applicant]
US 20020197705A1 · Kawaoka · 2002 [cited by applicant]
US 20030035814A1 · Kawaoka et al. · 2003 [cited by applicant]
US 20030044962A1 · Makizumi et al. · 2003 [cited by applicant]
US 20030073223A1 · Groner et al. · 2003 [cited by applicant]
US 20030119183A1 · Groner · 2003 [cited by applicant]
US 20030194694A1 · Kawaoka · 2003 [cited by applicant]
US 20030215794A1 · Kawaoka et al. · 2003 [cited by applicant]
US 20040002061A1 · Kawaoka · 2004 [cited by applicant]
US 20040029251A1 · Hoffman et al. · 2004 [cited by applicant]
US 20040057967A1 · Bavari et al. · 2004 [cited by applicant]
US 20040063141A1 · Lok · 2004 [cited by applicant]
US 20040077086A1 · Reiter et al. · 2004 [cited by applicant]
US 20040132164A1 · Doyle et al. · 2004 [cited by applicant]
US 20040142322A1 · Malcolm et al. · 2004 [cited by applicant]
US 20040219170A1 · Kawaoka · 2004 [cited by applicant]
US 20040241139A1 · Hobom et al. · 2004 [cited by applicant]
US 20040242518A1 · Chen et al. · 2004 [cited by applicant]
US 20050003349A1 · Kawaoka · 2005 [cited by applicant]
US 20050037487A1 · Kawaoka et al. · 2005 [cited by applicant]
US 20050095583A1 · Pekosz et al. · 2005 [cited by applicant]
US 20050118140A1 · Vorlop et al. · 2005 [cited by applicant]
US 20050158342A1 · Kemble et al. · 2005 [cited by applicant]
US 20050186563A1 · Hoffmann · 2005 [cited by applicant]
US 20050202553A1 · Groner et al. · 2005 [cited by applicant]
US 20050232950A1 · Kawaoka · 2005 [cited by applicant]
US 20050266023A1 · Bavari et al. · 2005 [cited by applicant]
US 20050266026A1 · Hoffmann et al. · 2005 [cited by applicant]
US 20060057116A1 · Kawaoka et al. · 2006 [cited by applicant]
US 20060088909A1 · Compans · 2006 [cited by applicant]
US 20060099609A1 · Bavari et al. · 2006 [cited by applicant]
US 20060134138A1 · Kawaoka et al. · 2006 [cited by applicant]
US 20060166321A1 · Kawaoka et al. · 2006 [cited by applicant]
US 20060188977A1 · Schwartz et al. · 2006 [cited by applicant]
US 20060216702A1 · Compans et al. · 2006 [cited by applicant]
US 20060240515A1 · Dimitrov et al. · 2006 [cited by applicant]
US 20060246092A1 · Neirynck et al. · 2006 [cited by applicant]
US 20070141699A1 · Kawaoka · 2007 [cited by applicant]
US 20070231348A1 · Kawaoka et al. · 2007 [cited by applicant]
US 20080009031A1 · Kawaoka · 2008 [cited by applicant]
US 20080187557A1 · Sambhara · 2008 [cited by applicant]
US 20080233560A1 · Hoffmann · 2008 [cited by applicant]
US 20080254067A1 · Trepanier et al. · 2008 [cited by applicant]
US 20080274141A1 · Groner et al. · 2008 [cited by applicant]
US 20080292658A1 · De Wit et al. · 2008 [cited by applicant]
US 20080293040A1 · Kawaoka et al. · 2008 [cited by applicant]
US 20080311148A1 · Hoffmann · 2008 [cited by applicant]
US 20080311149A1 · Hoffmann · 2008 [cited by applicant]
US 20090017444A1 · Kawaoka et al. · 2009 [cited by applicant]
US 20090047728A1 · Kawaoka et al. · 2009 [cited by applicant]
US 20090074812A1 · Watanabe et al. · 2009 [cited by applicant]
US 20090081252A1 · Gregersen · 2009 [cited by applicant]
US 20090181446A1 · Nouchi et al. · 2009 [cited by applicant]
US 20090311669A1 · Kawaoka · 2009 [cited by applicant]
US 20090324640A1 · Kawaoka et al. · 2009 [cited by applicant]
US 20100080825A1 · Kawaoka et al. · 2010 [cited by applicant]
US 20100112000A1 · Schwartz · 2010 [cited by applicant]
US 20100183671A1 · Gregersen et al. · 2010 [cited by applicant]
US 20100247572A1 · Kawaoka · 2010 [cited by applicant]
US 20100267116A1 · Kawaoka et al. · 2010 [cited by applicant]
US 20110020374A1 · Frazer · 2011 [cited by applicant]
US 20110027314A1 · Broeker · 2011 [cited by applicant]
US 20110045022A1 · Tsai · 2011 [cited by applicant]
US 20110081373A1 · Kawaoka et al. · 2011 [cited by applicant]
US 20110110978A1 · Kawaoka et al. · 2011 [cited by applicant]
US 20110159031A1 · Falkner et al. · 2011 [cited by applicant]
US 20110236417A1 · Watanabe et al. · 2011 [cited by applicant]
US 20110263554A1 · Kawaoka et al. · 2011 [cited by applicant]
US 20110300604A1 · Kawaoka et al. · 2011 [cited by applicant]
US 20120020997A1 · Hoffman et al. · 2012 [cited by applicant]
US 20120034600A1 · Gregersen · 2012 [cited by applicant]
US 20120058124A1 · Kurosawa et al. · 2012 [cited by applicant]
US 20120115206A1 · Schwartz et al. · 2012 [cited by applicant]
US 20120156241A1 · De Wit et al. · 2012 [cited by applicant]
US 20120207785A1 · Fabry et al. · 2012 [cited by applicant]
US 20120251568A1 · Garcia-Sastre et al. · 2012 [cited by applicant]
US 20130095135A1 · Collignon et al. · 2013 [cited by applicant]
US 20130183741A1 · Park et al. · 2013 [cited by applicant]
US 20130230552A1 · Kawaoka et al. · 2013 [cited by applicant]
US 20130243744A1 · Betenbaugh · 2013 [cited by applicant]
US 20130316434A1 · Reiter et al. · 2013 [cited by applicant]
US 20140227310A1 · Li et al. · 2014 [cited by applicant]
US 20150017205A1 · Kawaoka et al. · 2015 [cited by applicant]
US 20150166967A1 · Kawaoka et al. · 2015 [cited by applicant]
US 20150307851A1 · Kawaoka et al. · 2015 [cited by applicant]
US 20150368621A1 · Kawaoka et al. · 2015 [cited by applicant]
US 20160024193A1 · Ayalon et al. · 2016 [cited by applicant]
US 20160024479A1 · Kawaoka et al. · 2016 [cited by applicant]
US 20160115518A1 · Kawaoka et al. · 2016 [cited by applicant]
US 20160208223A1 · Kawaoka et al. · 2016 [cited by applicant]
US 20160215040A1 · Kyratsous et al. · 2016 [cited by applicant]
US 20160355790A1 · Kawaoka et al. · 2016 [cited by applicant]
US 20170058265A1 · Kawaoka et al. · 2017 [cited by applicant]
US 20170067029A1 · Kawaoka et al. · 2017 [cited by applicant]
US 20170096645A1 · Watanabe et al. · 2017 [cited by applicant]
US 20170097334A1 · Kawaoka et al. · 2017 [cited by applicant]
US 20170121391A1 · Kawaoka et al. · 2017 [cited by applicant]
US 20170258888A1 · Kawaoka · 2017 [cited by applicant]
US 20170298120A1 · Sasisekharan · 2017 [cited by applicant]
US 20170354730A1 · Kawaoka et al. · 2017 [cited by applicant]
US 20180245054A1 · Kawaoka et al. · 2018 [cited by applicant]
US 20180273588A1 · Kawaoka et al. · 2018 [cited by applicant]
US 20180340152A1 · Kawaoka et al. · 2018 [cited by applicant]
US 20190032023A1 · Kawaoka et al. · 2019 [cited by applicant]
US 20190048324A1 · Kawaoka et al. · 2019 [cited by applicant]
US 20190117759A1 · Wantanabe et al. · 2019 [cited by applicant]
US 20190167781A1 · Kawaoka et al. · 2019 [cited by applicant]
US 20200188506A1 · Kawaoka et al. · 2020 [cited by applicant]
US 20200237899A1 · Kawaoka et al. · 2020 [cited by applicant]
US 20200263142A1 · Kawaoka et al. · 2020 [cited by applicant]
US 20200263143A1 · Kawaoka et al. · 2020 [cited by applicant]
US 20200291384A1 · Kawaoka et al. · 2020 [cited by applicant]
US 20210061862A1 · Kawaoka et al. · 2021 [cited by applicant]
US 20210102178A1 · Kawaoka et al. · 2021 [cited by applicant]
US 20210121545A1 · Knoll et al. · 2021 [cited by applicant]
US 20210228708A1 · Smith et al. · 2021 [cited by applicant]
US 20210246432A1 · Kawaoka et al. · 2021 [cited by applicant]
US 20210252130A1 · Watanabe et al. · 2021 [cited by applicant]
US 20210290754A1 · Kawaoka et al. · 2021 [cited by applicant]
US 20210299249A1 · Kawaoka et al. · 2021 [cited by applicant]
US 20220025339A1 · Kawaoka et al. · 2022 [cited by applicant]
US 20220202926A1 · Kawaoka et al. · 2022 [cited by applicant]
US 20220241396A1 · Kawaoka et al. · 2022 [cited by applicant]
US 20230321217A1 · Kawaoka et al. · 2023 [cited by applicant]
US 20230346911A1 · Kawaoka et al. · 2023 [cited by applicant]
US 20240010995A1 · Kawaoka et al. · 2024 [cited by applicant]
US 20240076632A1 · Kawaoka et al. · 2024 [cited by applicant]
US 20240238403A1 · Kawaoka et al. · 2024 [cited by applicant]
US 20240318167A1 · Kawaoka et al. · 2024 [cited by applicant]
AU 2012204138B2 · 2014 [cited by applicant]
AU 2014202470 · 2016 [cited by applicant]
AU 2014290203B2 · 2020 [cited by applicant]
AU 2017221444B2 · 2021 [cited by applicant]
BR PI0410702B1 · 2022 [cited by applicant]
CA 2379012A1 · 2001 [cited by applicant]
CA 2816242C · 2019 [cited by applicant]
CN 1826407A · 2006 [cited by applicant]
CN 101472941A · 2009 [cited by applicant]
CN 1826407B · 2013 [cited by applicant]
CN 105296356A · 2016 [cited by applicant]
CN 103540614B · 2018 [cited by applicant]
CN 109477074A · 2019 [cited by applicant]
CN 113874496A · 2021 [cited by applicant]
CN 114929269A · 2022 [cited by applicant]
EP 0687471A1 · 1995 [cited by applicant]
EP 0700991A1 · 1996 [cited by applicant]
EP 0702085A1 · 1996 [cited by applicant]
EP 0704533A1 · 1996 [cited by applicant]
EP 1201760A1 · 2002 [cited by applicant]
EP 2010557B1 · 2014 [cited by applicant]
EP 1572910B1 · 2015 [cited by applicant]
EP 1631663B1 · 2016 [cited by applicant]
EP 2747778B1 · 2017 [cited by applicant]
EP 3009507B1 · 2020 [cited by applicant]
EP 2493912B1 · 2020 [cited by applicant]
EP 3022296B1 · 2022 [cited by applicant]
IL 171831A · 2015 [cited by applicant]
JP 07203958 · 1995 [cited by applicant]
JP 2002536992A · 2002 [cited by applicant]
JP 2003528570A · 2003 [cited by applicant]
JP 2004500842A · 2004 [cited by applicant]
JP 2004531232A · 2004 [cited by applicant]
JP 2005523698A · 2005 [cited by applicant]
JP 2005245302A · 2005 [cited by applicant]
JP 2005535288A · 2005 [cited by applicant]
JP 2006525815A · 2006 [cited by applicant]
JP 2007518395A · 2007 [cited by applicant]
JP 2007525175A · 2007 [cited by applicant]
JP 2007529997A · 2007 [cited by applicant]
JP 2008520248A · 2008 [cited by applicant]
JP 2009511984A · 2009 [cited by applicant]
JP 2009523252A · 2009 [cited by applicant]
JP 2009532352A · 2009 [cited by applicant]
JP 2010530248A · 2010 [cited by applicant]
JP 2011530295A · 2011 [cited by applicant]
JP 4927290 · 2012 [cited by applicant]
JP 4927290B2 · 2012 [cited by applicant]
JP 2013507990A · 2013 [cited by applicant]
JP 2013511289A · 2013 [cited by applicant]
JP 2014039551A · 2014 [cited by applicant]
JP 2014131516A · 2014 [cited by applicant]
JP 2016500007A · 2016 [cited by applicant]
JP 2016521553A · 2016 [cited by applicant]
JP 2015144463A · 2016 [cited by applicant]
JP 2016524915A · 2016 [cited by applicant]
JP 2016169225A · 2016 [cited by applicant]
JP 2017527557A · 2017 [cited by applicant]
JP 2017197555A · 2017 [cited by applicant]
JP 2018064493A · 2018 [cited by applicant]
JP 6352974B2 · 2018 [cited by applicant]
JP 6375329B2 · 2018 [cited by applicant]
JP 2019510481A · 2019 [cited by applicant]
JP 2020010711A · 2020 [cited by applicant]
JP 2020114250A · 2020 [cited by applicant]
JP 2021500891A · 2021 [cited by applicant]
JP 2021036878A · 2021 [cited by applicant]
JP 2021184761A · 2021 [cited by applicant]
JP 2021533157A · 2021 [cited by applicant]
JP 2021536228A · 2021 [cited by applicant]
JP 2022066209A · 2022 [cited by applicant]
JP 2022522112A · 2022 [cited by applicant]
JP 2022527235A · 2022 [cited by applicant]
JP 2022172369A · 2022 [cited by applicant]
JP 2022551805A · 2022 [cited by applicant]
KR 101113432B1 · 2012 [cited by applicant]
MX 285206 · 2011 [cited by applicant]
NO 341506 · 2017 [cited by applicant]
WO WO9610631A1 · 1996 [cited by applicant]
WO WO9610632A1 · 1996 [cited by applicant]
WO WO9640955A1 · 1996 [cited by applicant]
WO WO9737000A1 · 1997 [cited by applicant]
WO WO9802530A1 · 1998 [cited by applicant]
WO WO9848834A1 · 1998 [cited by applicant]
WO WO9853078A1 · 1998 [cited by applicant]
WO WO9928445A1 · 1999 [cited by applicant]
WO WO0053786A1 · 2000 [cited by applicant]
WO WO0060050A2 · 2000 [cited by applicant]
WO WO2000060050A2 · 2000 [cited by applicant]
WO WO0060050A3 · 2001 [cited by applicant]
WO WO2001004333A1 · 2001 [cited by applicant]
WO WO2001025462A1 · 2001 [cited by applicant]
WO WO0179273A2 · 2001 [cited by applicant]
WO WO2001079273A2 · 2001 [cited by applicant]
WO WO0183794A2 · 2001 [cited by applicant]
WO WO2001083794A2 · 2001 [cited by applicant]
WO WO0210143A1 · 2002 [cited by applicant]
WO WO02064757A2 · 2002 [cited by applicant]
WO WO02074795A2 · 2002 [cited by applicant]
WO WO03068923A2 · 2003 [cited by applicant]
WO WO2003068923A2 · 2003 [cited by applicant]
WO WO03076462A1 · 2003 [cited by applicant]
WO WO2003080846A1 · 2003 [cited by applicant]
WO WO03091401A2 · 2003 [cited by applicant]
WO WO2003091401A2 · 2003 [cited by applicant]
WO WO2004142322A1 · 2004 [cited by applicant]
WO WO2004094466A2 · 2004 [cited by applicant]
WO WO04112831A2 · 2004 [cited by applicant]
WO WO2004112831A2 · 2004 [cited by applicant]
WO WO2004112831A3 · 2004 [cited by applicant]
WO WO05028658A2 · 2005 [cited by applicant]
WO WO05028658A3 · 2005 [cited by applicant]
WO WO2005028658A2 · 2005 [cited by applicant]
WO WO2005062820A2 · 2005 [cited by applicant]
WO WO2006051069A2 · 2006 [cited by applicant]
WO WO2007004024A2 · 2007 [cited by applicant]
WO WO2007044024A3 · 2007 [cited by applicant]
WO WO2007126810A2 · 2007 [cited by applicant]
WO WO2007126810A3 · 2007 [cited by applicant]
WO WO2007146057A2 · 2007 [cited by applicant]
WO WO2007146057A3 · 2007 [cited by applicant]
WO WO08156681A3 · 2008 [cited by applicant]
WO WO2008147496A2 · 2008 [cited by applicant]
WO WO2008147496A3 · 2008 [cited by applicant]
WO WO2008155681A2 · 2008 [cited by applicant]
WO WO2008156778A2 · 2008 [cited by applicant]
WO WO2008156778A3 · 2008 [cited by applicant]
WO WO2008157583A1 · 2008 [cited by applicant]
WO WO09008921A3 · 2009 [cited by applicant]
WO WO09008921A9 · 2009 [cited by applicant]
WO WO2009007244A2 · 2009 [cited by applicant]
WO WO2009008921A2 · 2009 [cited by applicant]
WO WO2009014919A2 · 2009 [cited by applicant]
WO WO2008156778A9 · 2009 [cited by applicant]
WO WO09128867A2 · 2009 [cited by applicant]
WO WO2009152181A1 · 2009 [cited by applicant]
WO WO2009128867A3 · 2010 [cited by applicant]
WO WO2010053573A2 · 2010 [cited by applicant]
WO WO2010053573A3 · 2010 [cited by applicant]
WO WO2011014645A1 · 2011 [cited by applicant]
WO WO2011056591A1 · 2011 [cited by applicant]
WO WO2011087839A1 · 2011 [cited by applicant]
WO WO2011126370A1 · 2011 [cited by applicant]
WO WO2011130627A2 · 2011 [cited by applicant]
WO WO2012045882A2 · 2012 [cited by applicant]
WO WO2012177924A2 · 2012 [cited by applicant]
WO WO2013032942A1 · 2013 [cited by applicant]
WO WO2013032942A9 · 2013 [cited by applicant]
WO WO2013034069A1 · 2013 [cited by applicant]
WO WO2013087945A2 · 2013 [cited by applicant]
WO WO2013148302A1 · 2013 [cited by applicant]
WO WO2014195920A2 · 2014 [cited by applicant]
WO WO2015009743A1 · 2015 [cited by applicant]
WO WO2015134488A1 · 2015 [cited by applicant]
WO WO2015142671A2 · 2015 [cited by applicant]
WO WO2015196150A2 · 2015 [cited by applicant]
WO WO2015196150A3 · 2015 [cited by applicant]
Cited By (1)
US 12,365,880